3 results
Approved WMOCompleted
Primary: to assess the efficacy and safety of autologous epidermal cell suspension grafting using the ReCell kit after CO2 laser abrasion with superficial full surface ablation, fractional laser treatment and conventional (deep) full surface CO2…
Approved WMOCompleted
To evaluate the safety and efficacy of 12 weeks of linaclotide therapy in comparison with placebo in pediatric participants aged 6 to 17 years who fulfill modified Rome III Criteria for Child/Adolescent FC
Approved WMOCompleted
The objective of this study is to assess the long-term safety of linaclotide in pediatric participants with FC (total exposure with linaclotide for 24 weeks) or IBS-C (total exposure with linaclotide for 52 weeks) who have completed study…